PanoramicaGraficoNotizieSchermataTrader

Soc. Generale Knock-Out AMGN/  DE000SU6XB90  /

EUWAX
13/11/2024  21:36:16 Var.+1.46 Denaro22:00:40 Lettera22:00:40 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
15.77EUR +10.20% -
Quantità in denaro: -		 -
Quantità in lettera: -		 Amgen Inc 469.6021 USD 31/12/2078 Put
TeleTrader 12/11 Wall Street closes lower as markets brace for CPI data
TeleTrader 30/10 Amgen reports revenue of $8.5B in Q3, up 23%
TeleTrader 25/09 Dow falls 290 pts at close as S&P 500 slips from record highs
GlobeNewswire 29/08 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire 28/08 Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire 26/08 Molecular Partners Reports H1 2024 Corporate Highlights and Financials
GlobeNewswire 26/08 Eliem Therapeutics Announces Additions to its Leadership Team
GlobeNewswire 15/08 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire 12/08 TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08/08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/08 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
TeleTrader 07/08 US closes lower with earnings in focus
TeleTrader 07/08 US turns red, Dow loses more than 200 pts
GlobeNewswire 07/08 89bio Appoints Francis Sarena as Chief Operating Officer
TeleTrader 06/08 Amgen books revenue of $8.4B in Q2, up 20%
TeleTrader 06/08 US extends premarket gains, Dow surges 250 pts
GlobeNewswire 05/08 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
TeleTrader 01/08 Dow jumps 250 pts as Meta surges more than 10%
GlobeNewswire 01/08 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 22/07 Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 202...
GlobeNewswire 09/07 ImCheck Appoints Stephan Braun as Chief Medical Officer
GlobeNewswire 02/07 Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Bi...
GlobeNewswire 01/07 Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer
GlobeNewswire 27/06 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire 27/06 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...